粤开证券以“慢投资”之道陪伴企业成长

Core Viewpoint - Yuekai Securities, a state-owned comprehensive securities company, emphasizes a culture of compliance, integrity, professionalism, and stability, aiming to become a boutique broker in the Guangdong-Hong Kong-Macao Greater Bay Area, focusing on long-term investments in sectors like new energy, biomedicine, commercial aerospace, and low-altitude economy [1][2] Strategic Advantages - The company leverages its "professional judgment" and "state-owned attributes" to support patient capital, focusing on long-term value rather than short-term returns [2][3] - By enhancing its research capabilities, Yuekai Securities aligns its investment decisions with industry trends and project potential, identifying quality targets for long-term partnerships [2][3] Industry Focus - The company is strategically investing in new energy, biomedicine, commercial aerospace, and low-altitude economy, avoiding short-term speculation and focusing on technology-driven enterprises with core technologies and long-term growth potential [5][6] - The global market for AI data center energy storage batteries is projected to grow nearly 20 times from approximately 15 GWh in 2025 to over 300 GWh by 2030, indicating significant opportunities in the new energy sector [4] Investment Practices - Yuekai Securities adopts a "slow investment" approach, which involves patient capital and deep empowerment, allowing companies to navigate challenges and focus on core technology development [5][6] - The company has established a comprehensive empowerment system that integrates investment, investment banking, and wealth management, supporting companies throughout their growth cycles [6][7] Case Studies - In the low-altitude economy, Yuekai Capital led a strategic investment in XPeng Huitian, facilitating the construction of the world's first mass production flying car factory, with over 5,000 orders expected for delivery by 2026 [6][7] - In the biomedicine sector, Yuekai Capital has supported innovative companies like Anjisheng Biotech, accelerating the global clinical development of breakthrough treatments for severe diseases [7] Economic Impact - The company's investments are driving the formation of industrial clusters in commercial aerospace and low-altitude economy, contributing to regional industrial structure optimization and high-quality economic development [7]